Division of Vascular Surgery, Department of Surgery, University of Washington, Seattle, WA.
Division of Medical Genetics, Department of Internal Medicine, McGovern Medical School at UTHealth Houston, Houston, TX; Division of Cardiovascular Medicine, Department of Internal Medicine, McGovern Medical School at UTHealth Houston, Houston, TX.
Ann Vasc Surg. 2024 Aug;105:140-149. doi: 10.1016/j.avsg.2024.01.032. Epub 2024 Apr 8.
Engaging patients living with or at risk of aortic dissection via the Aortic Dissection Collaborative, physician education in vascular genetics was identified as a research priority. We surveyed vascular surgeons to characterize practice patterns, motivations, and barriers regarding aortopathy genetic testing.
An anonymous 27-question survey was distributed on social media platforms between November and December 2022. Domains included demographics, vascular genetic education, testing attitudes and utilization, and experience in treating patients with genetic vascular aortopathies. The analysis included summary statistics and unpaired t-test to compare responses by interest in incorporating testing and practice type.
A total of 171 vascular surgeons from 15 countries responded to the survey (23% trainees). Over half received vascular genetics education during training (59%), and most (86%) were interested in incorporating genetic testing into their practice. Academic surgeons were more likely to have cared for a patient with a known genetic aortopathy over the past year than surgeons in hospital-based and private practices (83% vs. 56% vs. 27%; P < 0.01), to have ever made a referral to a medical geneticist (78% vs. 51% vs. 9%; P < 0.01), and have access to genetic counselors or geneticists (66% vs. 46% vs. 0%; P < 0.01). Barriers to genetic testing were rated as more significant by surgeons in nonacademic practices, with top barriers being insurance coverage of testing, cost of genetic testing, and access to genetic counselors. Evidence-based professional society guidelines were the strongest rated motivating factor for testing incorporation among respondents.
Vascular surgeon attitudes are not major barriers to incorporating genetic testing for patients with aortopathies; however, practical challenges regarding genetic testing and counseling are barriers to implementation especially for vascular surgeons in nonacademic practices. Future efforts should focus on evidence-based society guidelines, continuing medical education to increase adoption, and facilitating access to genetic counseling.
通过主动脉夹层协作组织,使患有或有主动脉夹层风险的患者参与其中,医生在血管遗传学方面的教育被确定为研究重点。我们调查了血管外科医生,以描述他们在主动脉病变基因检测方面的实践模式、动机和障碍。
2022 年 11 月至 12 月,我们在社交媒体平台上分发了一份匿名的 27 个问题的调查。调查内容包括人口统计学、血管遗传学教育、检测态度和利用情况,以及治疗患有遗传性血管主动脉病变患者的经验。分析包括描述性统计和独立样本 t 检验,以比较对纳入检测和实践类型的兴趣的反应。
共有来自 15 个国家的 171 名血管外科医生对该调查做出了回应(23%为受训者)。超过一半的人在培训期间接受过血管遗传学教育(59%),大多数人(86%)有兴趣将基因检测纳入他们的实践。与医院基础和私人执业的外科医生相比,学术外科医生在过去一年中更有可能照顾过已知遗传性主动脉病变的患者(83%比 56%比 27%;P<0.01),更有可能向医学遗传学家转诊(78%比 51%比 9%;P<0.01),并且能够获得遗传咨询师或遗传学家(66%比 46%比 0%;P<0.01)。非学术实践中的外科医生认为基因检测的障碍更为重要,主要障碍是检测的保险覆盖范围、基因检测的成本以及获得遗传咨询师的机会。循证专业学会指南是受访者认为最能促进检测纳入的因素。
血管外科医生的态度并不是将基因检测纳入主动脉病变患者的主要障碍;然而,基因检测和咨询的实际挑战是实施的障碍,尤其是对于非学术实践中的血管外科医生。未来的努力应侧重于循证学会指南、增加采用的继续医学教育以及促进获得遗传咨询的机会。